Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Daily

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Virology|July 25, 2000
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activationL A Trimble, P Shankar, M Patterson, et al.
Tropical Medicine & International Health : TM & IH|November 3, 2005
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in SenegalD Ndiaye, J P Daily, O Sarr, et al.
Parasitology|June 10, 2003
Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in SenegalJ P Daily, C Roberts, S M Thomas, et al.
Acta Tropica|August 15, 2006
Defining the origin of Plasmodium falciparum resistant dhfr isolates in SenegalD Ndiaye, J P Daily, O Sarr, et al.
Journal of Pharmaceutical Sciences|October 6, 1998
Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivoL L von Moltke, D J Greenblatt, S X Duan, et al.
Journal of Clinical Pharmacology|February 28, 2001
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitorsL L von Moltke, D J Greenblatt, B W Granda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2000
Differential impairment of triazolam and zolpidem clearance by ritonavirD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Alprazolam-ritonavir interaction: implications for product labelingD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Journal of Clinical Pharmacology|April 29, 1998
Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.
Nature|November 30, 2007
Distinct physiological states of Plasmodium falciparum in malaria-infected patientsJ P Daily, D Scanfeld, N Pochet, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Virology|July 25, 2000
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activationL A Trimble, P Shankar, M Patterson, et al.
Tropical Medicine & International Health : TM & IH|November 3, 2005
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in SenegalD Ndiaye, J P Daily, O Sarr, et al.
Parasitology|June 10, 2003
Prevalence of Plasmodium falciparum pfcrt polymorphisms and in vitro chloroquine sensitivity in SenegalJ P Daily, C Roberts, S M Thomas, et al.
Acta Tropica|August 15, 2006
Defining the origin of Plasmodium falciparum resistant dhfr isolates in SenegalD Ndiaye, J P Daily, O Sarr, et al.
Journal of Pharmaceutical Sciences|October 6, 1998
Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivoL L von Moltke, D J Greenblatt, S X Duan, et al.
Journal of Clinical Pharmacology|February 28, 2001
Inhibition of human cytochrome P450 isoforms by nonnucleoside reverse transcriptase inhibitorsL L von Moltke, D J Greenblatt, B W Granda, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 10, 2000
Differential impairment of triazolam and zolpidem clearance by ritonavirD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Clinical Pharmacology and Therapeutics|May 9, 2000
Alprazolam-ritonavir interaction: implications for product labelingD J Greenblatt, L L von Moltke, J S Harmatz, et al.
Journal of Clinical Pharmacology|April 29, 1998
Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavirL L von Moltke, D J Greenblatt, J M Grassi, et al.
Nature|November 30, 2007
Distinct physiological states of Plasmodium falciparum in malaria-infected patientsJ P Daily, D Scanfeld, N Pochet, et al.
Pageof 1